263 related articles for article (PubMed ID: 2444951)
1. Concentration of biogenic amines and their metabolites in different parts of brain after experimental cerebral concussion.
Kmieciak-Kołada K; Felińska W; Stachura Z; Majchrzak H; Herman ZS
Pol J Pharmacol Pharm; 1987; 39(1):47-53. PubMed ID: 2444951
[TBL] [Abstract][Full Text] [Related]
2. Effects of meclofenoxate on the level and turnover of biogenic monoamines in the rat brain.
Petkov VV; Grahovska T; Petkov VD; Konstantinova E
Arzneimittelforschung; 1985; 35(12):1778-81. PubMed ID: 2420335
[TBL] [Abstract][Full Text] [Related]
3. Effect of T-2 toxin on brain biogenic monoamines in rats and chickens.
Boyd KE; Fitzpatrick DW; Wilson JR; Wilson LM
Can J Vet Res; 1988 Apr; 52(2):181-5. PubMed ID: 2453262
[TBL] [Abstract][Full Text] [Related]
4. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
[TBL] [Abstract][Full Text] [Related]
5. Lithium: modification of behavioral activity and brain biogenic amines in developing hyperthyroid rats.
Rastoge RB; Singhal RL
J Pharmacol Exp Ther; 1977 Apr; 201(1):92-102. PubMed ID: 850149
[TBL] [Abstract][Full Text] [Related]
6. Effect of triethyltin chloride on the central aminergic neurotransmitters and their metabolites: relationship with pathophysiology of aging.
Bentue-Ferrer D; Reymann JM; Van den Driessche J; Allain H; Bagot H
Exp Aging Res; 1985; 11(3-4):137-41. PubMed ID: 2416571
[TBL] [Abstract][Full Text] [Related]
7. Changes in dopamine, serotonin and their metabolites in discrete brain areas of rat offspring after in utero exposure to cocaine or related drugs.
Henderson MG; McMillen BA
Teratology; 1993 Nov; 48(5):421-30. PubMed ID: 7508151
[TBL] [Abstract][Full Text] [Related]
8. Effects of the ergot alkaloid elymoclavine on the level and turnover of biogenic monoamines in the rat brain.
Petkov VD; Konstantinova E
Arch Int Pharmacodyn Ther; 1986 May; 281(1):22-34. PubMed ID: 2428322
[TBL] [Abstract][Full Text] [Related]
9. Effects of dibutyryl cyclic GMP on the content of biogenic amines in discrete areas of brain and on the behaviour of rats.
Herman ZS; Kmieciak-Kołada K
Med Biol; 1978 Jun; 56(3):128-32. PubMed ID: 210334
[No Abstract] [Full Text] [Related]
10. Specificity of release of biogenic amines from isolated rat brain tissue as a function of the meta substituent of N-ethylamphetamine derivatives.
Tessel RE; Rutledge CO
J Pharmacol Exp Ther; 1976 May; 197(2):253-62. PubMed ID: 1271279
[TBL] [Abstract][Full Text] [Related]
11. Effect of methionine on the brain biogenic monoamines and on the cortical bioelectrical activity of rabbits.
Kleinrok Z; Przegaliński E; Lasarova M; Roussinov KS; Sokolov V
Pol J Pharmacol Pharm; 1977; 29(4):377-84. PubMed ID: 905205
[TBL] [Abstract][Full Text] [Related]
12. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain.
Gagnaire F; Chalansonnet M; Carabin N; Micillino JC
Arch Toxicol; 2006 Oct; 80(10):703-12. PubMed ID: 16518643
[TBL] [Abstract][Full Text] [Related]
13. Influence of dibutyryl cyclic AMP on the level of catecholamines and 5-hydroxytryptamine in discrete areas of rat brain.
Herman ZS; Kmieciak-Kolada K; Drybański A
Med Biol; 1977 Jun; 55(3):177-80. PubMed ID: 197324
[TBL] [Abstract][Full Text] [Related]
14. Effect of yohimbine on brain monoamines: an in vivo study.
Brannan T; Martinez-Tica J; Yahr MD
J Neural Transm Park Dis Dement Sect; 1991; 3(2):81-7. PubMed ID: 1716906
[TBL] [Abstract][Full Text] [Related]
15. Zolpidem, a novel nonbenzodiazepine hypnotic. II. Effects on cerebellar cyclic GMP levels and cerebral monoamines.
Scatton B; Claustre Y; Dennis T; Nishikawa T
J Pharmacol Exp Ther; 1986 May; 237(2):659-65. PubMed ID: 2871179
[TBL] [Abstract][Full Text] [Related]
16. Mouse strain-dependent effect of amantadine on motility and brain biogenic amines.
Messiha FS
Arch Int Pharmacodyn Ther; 1989; 302():74-85. PubMed ID: 2484011
[TBL] [Abstract][Full Text] [Related]
17. Biogenic amines and ascorbic acid in rat brain following steroid contraceptive treatment.
Dey CD; Das PC; Das K; Patra PB; Dasgupta S
Exp Clin Endocrinol; 1991 Mar; 97(1):103-6. PubMed ID: 1864309
[TBL] [Abstract][Full Text] [Related]
18. Neurochemical studies on central dopamine neurons--regional characterization of dopamine turnover.
Hallman H; Jonsson G
Med Biol; 1984; 62(3):198-209. PubMed ID: 6492900
[TBL] [Abstract][Full Text] [Related]
19. The effect of alpha-adrenergic receptor blockers prazosin and yohimbine on cerebral metabolism and biogenic amine content of traumatized brain.
Inoue M; McHugh M; Pappius HM
J Cereb Blood Flow Metab; 1991 Mar; 11(2):242-52. PubMed ID: 1705253
[TBL] [Abstract][Full Text] [Related]
20. Effects of acute administration of cyclazocine on the metabolism of biogenic amines in different regions of rat brain.
Gavend MM; Serre F; Gavend MR; Ragoucy C; Caron P
Psychopharmacology (Berl); 1981; 75(1):79-83. PubMed ID: 6171003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
